Work

SAT0531 Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the giacta trial

Year: 2018

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2018-eular.2719

Authors: J.H. Stone, K. Tuckwell, S. Dimonaco, M. Klearman, M. Aringer, D. Blockmans, E. Brouwer, M.C. Cid, B. Dasgupta, J. Rech, C. Salvarani, H. Schulze-Koops, G. Schett, R. Spiera, S.H. Unizony, N. Collinson

Institutions: Harvard University, Massachusetts General Hospital, Genentech, Roche (United Kingdom), Universitair Ziekenhuis Leuven, University Medical Center Groningen, University of Groningen, Universitat de Barcelona, Southend University Hospital NHS Foundation Trust, Southend Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Santa Maria Nuova Hospital, Ludwig-Maximilians-Universität München, Universitätsklinikum Erlangen, Hospital for Special Surgery, Cornell University

Language: English

Topic: Vasculitis and related conditions

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: F. Hoffmann-La Roche

OpenAlex ID: W2808446992

Cites:

Cited by: 2

Related to: 10